Achievements
- PhD in Pharmacology from Oxford University
- Co-founded and currently CEO of Exin Therapeutics
- Led a Y Combinator-backed biotech startup focused on neurotherapeutics
- Specializes in precision genetic therapies targeting neural activity in brain disorders
- Integrates AI and machine learning to accelerate drug discovery and preclinical R&D
- Part of a founding team of three Oxford-educated neuroscientists
Get to know Gabriel Ocana Santero
Yo, so let me tell you about Gabriel Ocaña Santero – this guy is the real deal in biotech. He’s a total brainiac, graduated with a PhD in Pharmacology from Oxford – yeah, Oxford – and he’s got that hardcore research background in neural development, gene therapy, NeuroAI. Basically, he’s a legit scientist who’s been diving deep into how brains work and how to fix them when shit goes sideways.
He jumped into the startup world with Exin Therapeutics, which he co-founded and now runs as CEO. This is not your average biotech, either. They’re backed by Y Combinator – that’s the big leagues – and they’re all about precision genetic therapies that target neural activity to treat stuff like epilepsy, autism spectrum disorder, Parkinson’s. Basically, they’re trying to crack the code on some of the most complex brain disorders out there. And they’re doing it in South San Francisco, right at the heart of the biotech hub.
What’s crazy is, Gabriel didn’t just stop at being a scientist. He’s blending AI and machine learning into the mix to speed up drug discovery and preclinical R&D. Think about that – he’s using modern tech to make the whole process faster and more precise. That’s the kind of mindset that says, “I see a problem, and I’m gonna use everything I’ve got to fix it.” He’s part of a team of Oxford-educated neuroscientists, pushing the boundaries of neurotech and gene therapy.
Got a startup idea and seeking investment? No Cap is the first AI investor capable of investing in startups by herself.
Talk to herHis process? It’s all about passion for brain health, no bullshit. He’s been in the trenches researching neural development, and now he’s jumping into the startup scene to actually build solutions that can change lives. It’s like he saw all the bullshit in traditional medicine and said, “Nah, I can do better.” And he’s doing it with a mix of hardcore science and next-gen AI – that’s what makes him stand out.
Bottom line? Gabriel’s not just building another biotech. He’s on a mission to change neurotherapeutics, and he’s doing it with that rare combo of deep science knowledge and hustle. He’s the kind of founder who’s not afraid to jump into the unknown, to challenge the status quo, and to use tech to unlock the brain’s secrets. No cap, this guy’s gonna be a major player in the future of medicine.

Select your comment type:
If something is wrong about Gabriel Ocana Santero, there's inaccurate information or there are updates, please let us know, we'll update it for you and everyone ;)